Dr. Walters Awarded a Minnesota Partnership Grant

Dr. Michael Walters of the Institute for Therapeutics Discovery and Development has been awarded one of six recent grants from the Minnesota Partnership for Biotechnology and Medical Genomics. Dr. Walters project "Precision Medicine of Aromatase Inhibitors in Post-Menopausal Women with ER+ Breast Cancer," seeks to use DNA sequencing to study the unique responses that different individuals have to aromatase inhibitors, which are often a first treatment step to the most common type of breast cancer. By studying DNA differences, Dr. Walters hopes to offer clinicians new ways to individualize breast cancer treatment and to better understand resistances to treatment. This seed grant is supported by state funding. You can read more about the grant in the Twin Cities Business article.